Lymphoma, Large Cell Withdrawn Phase 1 Trials for CD-16 NK-92 cells (DB17465)

Also known as: Large Cell Lymphoma / Lymphoma, Large-Cell / Large-cell Lymphoma

IndicationStatusPhase
DBCOND0032452 (Lymphoma, Large Cell)Withdrawn1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04052061QUILT-3.061: CD19 t-haNK in Subjects With Diffuse Large B-Cell LymphomaTreatment